FCHO1

FCHO1 is an early-acting endocytic pioneer that nucleates clathrin-coated pit formation by coupling membrane curvature sensing to adaptor activation and cargo recruitment. Its N-terminal F-BAR domain binds and bends membranes, while its C-terminal μ-homology domain (μ-HD) serves as a versatile interaction hub that directly engages arrayed DPF motifs in Eps15/R, forming transient ternary nanoclusters with AP-2; the FCHO1 interdomain linker facilitates conformational activation of AP-2 to promote cargo engagement (PMID:27237791). The μ-HD also directly binds the BMP receptor Alk8 to modulate receptor endocytosis and signaling in vivo (PMID:22484487), and disease-causing FCHO1 mutations that disrupt protein localization or partner interactions impair clathrin-coated pit formation and TCR internalization in T cells (PMID:32098969). At central synapses, FCHO1 operates in a demand-sensitive manner: the F-BAR domain supports basal synaptic vesicle retrieval, whereas the μ-HD becomes essential under high-frequency stimulation (PMID:41943152).

1. 2007 Low

   Initial live-cell imaging linked FCHO1 dynamics to clathrin-coated vesicle formation by showing that GFP-FCHO1 intensity oscillates with periodicity matching clathrin at perinuclear regions, establishing FCHO1 as temporally coordinated with the clathrin coat cycle.

   Evidence Live-cell fluorescence imaging of GFP-FCHO1 in mammalian cells

   PMID:17617719

   Open questions at the time

   • No functional perturbation performed; correlation does not demonstrate causality
   • Overexpression of GFP-fusion may not reflect endogenous behavior
   • No binding partners or domain requirements identified
2. 2012 High

   The question of whether FCHO1 has functions beyond coat assembly was answered by showing that the μ-HD directly binds the BMP receptor Alk8 and that fcho1 loss in zebrafish impairs BMP signaling, establishing FCHO1 as a cargo-selective endocytic modulator for receptor signaling.

   Evidence Co-immunoprecipitation of μ-HD with Alk8; morpholino knockdown in zebrafish with genetic epistasis versus AP-2

   PMID:22484487

   Open questions at the time

   • Structural basis of μ-HD–Alk8 interaction not resolved
   • Whether mammalian FCHO1 similarly regulates BMP signaling not tested
3. 2016 High

   The molecular mechanism by which FCHO1 activates AP-2 was elucidated: crystal structures showed that the μ-HD decodes arrayed DPF motifs in Eps15/R in a spacing-dependent manner distinct from AP-2, and the interdomain linker enables conformational opening of AP-2 for cargo binding, establishing the FCHO1–Eps15/R–AP-2 ternary nanocluster as the functional unit for endocytic initiation.

   Evidence Crystal structure of Eps15/R·Fcho1 μ-HD complex; FCHO1/2 knockout cells; mutagenesis and rescue

   PMID:27237791

   Open questions at the time

   • How the ternary nanocluster transitions to a mature clathrin-coated pit is not defined
   • Relative contributions of FCHO1 versus FCHO2 in different cell types remain unclear
4. 2020 High

   The pathophysiological relevance of FCHO1 was established when disease-causing mutations were shown to either mislocalize the protein or abolish partner interactions, impairing clathrin-coated pit formation and TCR internalization in T cells, directly linking FCHO1 loss-of-function to human immunodeficiency.

   Evidence Live-cell imaging of patient-derived FCHO1 mutants; CRISPR knockout and shRNA in Jurkat cells with wild-type rescue

   PMID:32098969

   Open questions at the time

   • Which specific interaction is disrupted by each mutation not fully mapped
   • Whether FCHO1 deficiency affects endocytosis of receptors beyond TCR in T cells not systematically tested
5. 2024 Medium

   Ortholog studies in yeast showed that Syp1 (FCHO1/2 ortholog) cooperates with CALM/AP180 family proteins and anionic lipids to trigger Ede1 (Eps15)-centric CME initiation preferentially in cargo- and lipid-rich membrane regions, establishing an evolutionarily conserved mechanism for site selection during endocytic initiation.

   Evidence Live-cell imaging and double-mutant genetics in budding yeast comparing CME dynamics in mother versus daughter cells

   PMID:39316607

   Open questions at the time

   • Direct functional equivalence of Syp1 and mammalian FCHO1 not demonstrated by cross-species rescue
   • Whether lipid-dependent site selection also applies in mammalian cells not tested
6. 2026 High

   The long-standing question of whether FCHO1 functions at synapses and how its domains contribute was resolved: the F-BAR domain is sufficient for basal synaptic vesicle endocytosis, but the μ-HD becomes essential under high-frequency stimulation, establishing FCHO1 as a demand-sensitive endocytic scaffold at central synapses.

   Evidence shRNA knockdown with pHluorin-based live imaging of synaptic vesicle recycling; domain-specific rescue constructs in neurons

   PMID:41943152

   Open questions at the time

   • Identity of μ-HD binding partners at synapses that are required under high stimulation is unknown
   • Whether FCHO2 compensates at synapses is not addressed

• Key unresolved questions include the full repertoire of cargo receptors and signaling receptors engaged by the FCHO1 μ-HD, how FCHO1 versus FCHO2 are differentially deployed across tissues, whether FCHO1 phosphorylation by PKB regulates endocytic function in vivo, and how the transient nanocluster matures into a productive clathrin-coated pit.
• No in vivo phospho-site mutagenesis of endogenous FCHO1
• FCHO1/FCHO2 tissue-specific functional redundancy not systematically addressed
• Structural basis for activity-dependent μ-HD requirement at synapses unknown